Medtronic plc , a global leader in healthcare technology, announced it has received approval from Japan's Ministry of Health, Labor and Welfare for the...
COUR Pharmaceuticals, a biotechnology company developing novel immune-modifying nanoparticles (CNPs) to treat immune disorders, today announced the U.S. Food and Drug Administration (FDA) granted...
With a steadfast commitment to protecting personal healthcare information, Coriell Life Sciences (CLS) – a leader in precision medicine dedicated to personalized medication safety...
Golden Biotechnology Corp., a leading Taiwanese biopharmaceutical company, announces that its Phase 2 COVID-19 trial for oral new drug Antroquinonol has achieved 100% recovery...
Laekna Therapeutics announced that the investigational new drug (IND) application of a combination therapy for the phase 1/2 clinical trial in patients with solid...
